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A B S T R A C T
We present a 62-year-old lady admitted in our hospital with two episodes of acute ischemic stroke about
2 weeks apart. She was evaluated for acute ischemic stroke and was thrombolysed for recent stroke in
right MCA territory ﬁrst time. On further evaluation, she was found to have a RVOTmass. A transthoracic
and transesophageal echocardiogram revealed a PFO and a large, 5.1 cm  2.3 cm, ovoid, well
circumscribed, echogenic mass in the right ventricle outﬂow tract attached by small pedicle to the
ventricular side of anterior tricuspid leaﬂet, partly obstructing the right ventricular outﬂow tract and
protruding through the pulmonic valve during systole. She was scheduled for surgery (right ventricular
mass excision and PFO closure) after 3 weeks due to the risk of secondary hemorrhage in the infarcted
area following thrombolysis and anticoagulation and so was discharged with medications after full
neurologic recovery after about a week of hospital stay.
She was readmitted 7 days after discharge, before the scheduled date of surgery with history of
weakness of right upper limb, slurred speech and mild breathing difﬁculty lasting for about 20 min
following which she improved slowly (transient ischemic attack). The tumor was completely removed
with the stalk using cardiopulmonary bypass support. The histopathological ﬁndings conﬁrmed the
diagnosis of myxoma.
 2016 Published by Elsevier B.V. on behalf of Cardiological Society of India. This is an open access article
under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Primary tumors of the heart are rare with the incidence of
0.02–0.05%.1 Cardiac myxomas are rare benign tumors, which
account for nearly 50% of all adult primary cardiac tumors.2
Approximately 75–80% of myxomas are located in the left
atrium, 10–20% are in the right atrium, and 5–10% are in both atria
or either ventricle.3
Typically, solitary, pedunculated, and arising in the vicinity of
the fossa ovalis, they may on occasion be multicentric, sessile, or
attached to other areas of endocardium.Myxomas arising from the
right ventricle are extremely rare.4,5
Clinically they present with symptoms of hemodynamic
obstruction, embolization or constitutional changes. Diagnosis at
present is established most appropriately with two dimensional
echocardiography.6 Prompt excision using cardiopulmonaryAbbreviations: RV, right ventricle; RVOT, right ventricle outﬂow tract; TIA, transient
ischemic attack; MCA, middle cerebral artery; MRI, magnetic resonance imaging;
HPE, histo pathologic examination; PFO, patent foramen ovale.
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creativecommons.org/licenses/by-nc-nd/4.0/).bypass, ﬁrst carried out by Crafoord in 1954,7 has been established
as the only acceptable mode of treatment for these tumors.8
The surgeon must try to prevent fragmentation and intraop-
erative embolization of the tumor, postoperative recurrence and
the missing of an occasional multicentric lesion. During the past
ﬁve decades multiple centers have shown excellent surgical
therapy results with a decreasing mortality.
We reported a patient with myxoma located in the right
ventricle resulting in paradoxical embolization and recurrent
stroke.
2. Case report
We present a 62-year-old lady admitted in our hospital with
history of weakness of left upper limb and slurred speech which
lasted for about 20 min. She was evaluated for acute ischemic
stroke. Neurological examination revealed conscious, oriented
patient withmild dysarthria, left upper limbweakness with power
4/5. Clinical examination revealed systolic murmur at the left
upper sternal border. She was investigated to ﬁnd the cause for
stroke like ECG, 2-D echo, coronary angiogram, carotid Doppler,
EEG, coagulation proﬁle, ultrasound abdomen, which wereIndia. This is an open access article under the CC BY-NC-ND license (http://
P.A.S. Rao et al. / Indian Heart Journal 68 (2016) S97–S101S98reported as normal. Ventilation perfusion scan was not done as
patient did not show signs of oxygen desaturation at the time of
this event.
MRI brain revealed an acute infarct in the right MCA territory
and on further cardiac evaluation was found to have a right
ventricular mass and a small patent foramen ovale; mitral valve
proplase (PML proplapse) with moderate mitral regurtitation and
good left ventricular function. She was thrombolysed with
recombinant tissue plasminogen activator and was scheduled
for surgery (right ventricular mass excision and PFO closure) after
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Fig. 1. MRI shows hyperintense signa3 weeks due to the risk of secondary hemorrhage in the infracted
area following thrombolysis and anticoagulation and so was
discharged with medications after full neurologic recovery after
about a week of hospital stay.
Shewas readmitted 7 days after discharge, before the scheduled
date of surgery with history of weakness of right upper limb,
slurred speech and mild breathing difﬁculty lasting for about
20 min following which she improved slowly (transient ischemic
attack). MRI brain (Fig. 1) showed T2 FLAIR images (A) showed
hyperintense signals in right pre- and post-central gyri withls in pre- and post-central gyri.
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(B) suggestive of acute infarct. We decided to go ahead with the
surgery after second episode of stroke.
This lady presented with recurrent stroke probably due to
paradoxical embolization of tumor tissue through PFO. Transeso-
phageal echo (Figs. 2–5) revealed attachment of right ventricular
myxoma to the ventricular side of anterior tricuspid leaﬂet close to
PFO which could have embolized to brain resulting in stroke.
Intraoperatively, it was noted that PFO was signiﬁcantly large
about 1 cm2 as compared to TEE ﬁnding hence, was closed with a
pericardial patch and was situated close to the fragile tumor tissue
attached to tricuspid leaﬂet. An event like coughing, sneezing or
straining could have triggered a right to left shunt across the PFO
resulting from high intrathoracic pressure and raised central[(Fig._2)TD$FIG][(Fig._4)TD$FIG]
Fig. 4. TEE-RV inﬂow–outﬂow view: large oval shapemyxoma in RV extending from
tricuspid valve to pulmonary valve.
[(Fig._3)TD$FIG]
Fig. 3.Modiﬁed bicaval view: PFOwith RVmyxoma attachment to tricuspid leaﬂet.
Fig. 2. Deep transgastric RV outﬂow view: RV myxoma obstructing RVOT and
protruding into pulmonary valve during systolae.
Fig. 5. Deep transgastric RV apical view: RV myxoma attachment to anterior
tricuspid leaﬂet by a stalk.venous pressure leading to a possible paradoxical embolization of
fragile tumor tissue.
The patient was operated on using the extracorporeal circula-
tion. Cardiopulmonary bypass was instituted with the bicaval
cannulation; returning blood to the ascending aorta. Both venae
cavae were snared and right atrium was opened. The tumor was
excised in multiple fragments (gelatinous grayish-brown tissue)
together with the stalk and tumor base was thermocauterized and
the resultant rent in the anterior leaﬂet of the tricuspid valve was
sutured using 6 ‘o’ prolene. Tricuspid valve coaptation and
competence was checked and found intact. Saline wash and
lavage of the chambers was done.
Patent foramen ovale was closed with the pericardial patch
using 4 ‘o’ prolene and thereupon the right atriumwas sutured. The
patient was weaned from cardiopulmonary bypass and the chest
was closed routinely. Postoperative course was uneventful.
Pathologically, the macroscopic specimen demonstrated the jelly
like mass with hemorrhagic areas (Fig. 6). The histopathological
ﬁndings conﬁrmed the diagnosis of myxoma (Fig. 7). Our patient
had no episodes of stroke/TIA after nearly 1 year of follow up
following surgery and has full neurological recovery.
3. Discussion
Primary heart tumors are rare and the majority of them are
atrial myxomas. Only sporadic cases of myxomas arising from the
right ventricular outﬂow tract have been reported in the
literature.9,10 Clinical symptoms of myxomas depend on its
position and size, are atypical and vary to a large extent in terms
of general symptoms, heart symptoms and embolic events.
A higher frequency of embolization up to 30–40% was reported
in western series.11,12 The majority of patients have a variety of
[(Fig._6)TD$FIG]
Fig. 6. Gross appearance: macroscopic specimen demonstrated the jelly like mass
with hemorrhagic areas.
[(Fig._7)TD$FIG]
Fig. 7.HPE of specimen HPE of the specimen showed loosemyxoid areas, composed
of spindle cells with myxomatous matrix around them. No evidence of
pleomorphism, mitosis or other features suggestive of malignancy.
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myxomas ‘‘the great masque rader’’. Asymptomatic cases are rare.
Screening for myxoma is important in cases of family history, in
complex myxoma, or Carney disease.13
Patent foramen ovale (PFO) is a common ﬁnding in general
population; it is not classiﬁed as an atrial septal defect. It is
anatomically tunnel-like structure between the upper rim of the
fossa ovalis limb and the fossa ovalis valve, and is the result of the
lack of fusion of the septum primum and septum secundum. The
length of the tunnel varies, ranging from 3 to 24 mm, with the
mean length of 9 mm.27,28
PFO in adults does not usually produce a signiﬁcant shunt. Its
potential risk is that it allows paradoxical embolism into the
systemic vascular bed in the presence of venous thrombosis or
right atrial thrombosis or thrombosis directly inside the PFO tunnel
or atrial septal aneurysm, in hypercoagulation state or when using
hormonal contraception.
A right-to-left shunt may be transient or intermittent: it is
caused by increased right atrial pressure in pulmonary embolism
or lung disease but, also, in cough, Valsalva maneuver or diving,
and it may also be dependent on a change in position.29
Our patient had atypical symptoms and the diagnosis was made
by echocardiography. Echocardiography is non-invasive and allows
preoperative diagnosis with fair degree of accuracy. It can rule out
tumor in other chambers and there is no risk of tumor embolization.
Transthoracic echocardiography can generally be used to determine
the location, size, shape, attachment and mobility of a tumor.
The transesophageal approach is particularly helpful in
detecting the site of insertion and morphological features of atrial
and ventricular myxomas.14 We have come to rely solely on two
dimensional echocardiography for preoperative diagnosis and
believe that catheterization, a potentially harmful procedure in
myxoma, is not indicated for diagnosis.11
However, if coronary artery disease is suspected, or patient’s
age is greater than 40 years, coronary arteriography is advised to
evaluate the coronary arteries. Once the diagnosis of cardiac
myxoma is made, the operation should be carried out without
delay.15 Surgical excision of right ventricular myxomas must be
accomplished as soon as possible after the diagnosis has been
established to prevent serious complications such are valvular
obstruction, pulmonary embolization and syncope.
Surgical intervention offers the cure for patients with sporadic
intracardiac myxomas. Recurrence of a sporadic myxoma is
unusual, occurring in 1–3% of cases.16,17 The risk of recurrence
after surgery is correlated with young age, family history of
myxoma,18,19 inadequate resection, intraoperative implantation or
multicentre growth. Recently, interleukin-620 and endothelial
growth factor21 have been identiﬁed as markers of these tumors.The average recurrence occurs about 30 months after removal of
the ﬁrst myxoma.22 Familial myxomas have greater tendency to
recur, even many years after the operation. Although only several
cases of recurrence of the right ventricular myxoma have been
reported so far,23,24 routine echocardiography control after the
operation is advised.
HPE of the specimen showed loose myxoid areas, composed of
spindle cells with myxomatous matrix around them. No evidence
of pleomorphism, mitosis or other features suggestive of
malignancy.
A regular follow up of all patients by non-invasive method is
mandatory because the recurrence of myxoma have been
documented at various intervals and are not clearly predictable.25
A high incidence of arrythmias and conduction disturbances, both
early and late, have been reported by Bateman and colleagues.26
Although the pathophysiology of this was unclear, they were
thought to be related to a possible surgical injury to the conduction
pathways (biatrial approach) or excessive retraction of the heart
(atrial approach). Operative mortality and morbidity is low as
reported by others.10,13,16
4. Conclusion
The presented case illustrates the usefulness of transesophageal
echo-cardiography both in diagnosing and planning surgical
approach in patients with the myxomas. It also stresses the
importance of surgical excision of the tumor as soon as possible
following the diagnosis to prevent serious complications.
These tumors can be excised with a low rate of morbidity and
mortality. The prognosis for patients after surgical resection is
excellent. This is probably the ﬁrst case of RV myxoma presenting
as recurrent stroke. Our patient had no episodes of stroke/TIA after
nearly 1 year of follow up following surgery and has full
neurological recovery.
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